The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

Phase 3 Completed 12 enrolled The Hospital for Sick Children

NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to study the acute effects of angiotensin-converting enzyme inhibitor (ACEI) on systemic, pulmonary and cerebral blood flow in post bidirectional cavopulmonary connection (BCPC) patients.

Timeline

Start: 2008-07
Primary completion: 2010-01
Completion: 2010-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ENALAPRILAT ANHYDROUS	Small molecule	0.005 mg/kg	Intravenous
Subject	ENALAPRILAT ANHYDROUS	Small molecule	0.01 mg/kg	Intravenous

The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

Summary

Timeline

Drugs

Indications